ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,214.08
0.51%
Dow Jones
39,387.76
0.85%
US Dollar vs MXN
16.794
-0.74%
Brent Oil
83.95
0.47%
Bitcoin
63,086.86
3.10%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Vickers Vantage Corporation I (VCKA)

  7. Vickers Vantage Corporation I (VCKA) Noticias

VCKA

Vickers Vantage Corporat... (VCKA)

Vickers Vantage Corporation I
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:VCKA
FechaHoraFuenteTítuloSímboloCompañía
28/06/202305:15Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:VCKAVickers Vantage Corporation I
22/06/202305:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VCKAVickers Vantage Corporation I
20/06/202305:02Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:VCKAVickers Vantage Corporation I
12/05/202315:02Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:VCKAVickers Vantage Corporation I
09/05/202305:01Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:VCKAVickers Vantage Corporation I
20/04/202305:05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:VCKAVickers Vantage Corporation I
10/04/202316:16Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:VCKAVickers Vantage Corporation I
05/04/202316:28Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:VCKAVickers Vantage Corporation I
14/03/202315:03Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:VCKAVickers Vantage Corporation I
07/03/202316:13Edgar (US Regulatory)Annual Report (10-k)NASDAQ:VCKAVickers Vantage Corporation I
03/03/202308:11Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:VCKAVickers Vantage Corporation I
13/02/202312:53Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:VCKAVickers Vantage Corporation I
23/01/202315:12Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VCKAVickers Vantage Corporation I
29/11/202210:44Edgar (US Regulatory)Sec Staff Action/letter (sec Staff)NASDAQ:VCKAVickers Vantage Corporation I
10/11/202215:00Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:VCKAVickers Vantage Corporation I
31/10/202208:00GlobeNewswire Inc.Scilex Holding Company (“Scilex”), a Sorrento Company (nearly 100% or over 99.9% majority-owned subsidiary of Sorrento Therapeutics, Inc.) (Nasdaq: SRNE, “Sorrento”), and Vickers Vantage Corp. I Announce Effectiveness of Registration Statement on FNASDAQ:VCKAVickers Vantage Corporation I
27/10/202214:33Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:VCKAVickers Vantage Corporation I
18/10/202216:07Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:VCKAVickers Vantage Corporation I
30/08/202222:21GlobeNewswire Inc.Scilex Holding Company, a Sorrento Company, Announces That the FDA Has Granted Fast Track Designation for SP-103 (Lidocaine Topical System) 5.4%, Next Generation Triple Strength Formulation of ZTlido®, for the Treatment of Acute Low Back Pain (LBP)NASDAQ:VCKAVickers Vantage Corporation I
17/08/202208:00GlobeNewswire Inc.Scilex Holding Company, a Sorrento Company, Announces Exclusive Product Distribution Agreement with CH Trading Group LLC to Expand Commercialization of ZTlido® across certain designated territories including Middle East and North AfricaNASDAQ:VCKAVickers Vantage Corporation I
16/08/202208:00GlobeNewswire Inc.Scilex Holding Company, a Sorrento Company, Announces Expanding Coverage to 30 Million Lives And Will Continue To Work To Access An Additional 20 Million Lives With One Of The Largest National Pharmacy Benefit Managers (PBMs) For ZTlido® (lidocaine topicaNASDAQ:VCKAVickers Vantage Corporation I
07/07/202208:30GlobeNewswire Inc.Scilex Holding Company, a Sorrento Company, Has Entered A Term Sheet to Acquire Ancora Medical Inc.NASDAQ:VCKAVickers Vantage Corporation I
05/07/202213:04GlobeNewswire Inc.Scilex Holding Company, a Sorrento Company, announces that the Honorable Tommy G. Thompson has joined the Scilex Board of DirectorsNASDAQ:VCKAVickers Vantage Corporation I
14/06/202209:33GlobeNewswire Inc.Scilex Holding Company, a Sorrento Company, enters into an agreement for an exclusive license with ROMEG Therapeutics, LLC, for the right to commercialize Gloperba®, an FDA-approved prophylactic treatment for painful gout flares in adults, in the US.NASDAQ:VCKAVickers Vantage Corporation I
07/06/202207:45Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:VCKAVickers Vantage Corporation I
03/06/202208:00GlobeNewswire Inc.Scilex Holding Company, a Sorrento Company, Announces Pre-Emptive Repurchase of $41.4 Million of its Senior Secured NotesNASDAQ:VCKAVickers Vantage Corporation I
18/05/202208:30GlobeNewswire Inc.Scilex, a Sorrento Company, Announces Initiation of a Phase 2 Study to Evaluate the Safety and Efficacy of SP-103 in Subjects with Acute Low Back PainNASDAQ:VCKAVickers Vantage Corporation I
16/05/202208:00GlobeNewswire Inc.Scilex Holding Company, a Sorrento Company, and Vickers Vantage Corp. I announced today the filing of a Registration Statement on Form S-4 with the Securities and Exchange Commission relating to the previously announced proposed business combination betweeNASDAQ:VCKAVickers Vantage Corporation I
11/05/202208:00GlobeNewswire Inc.Scilex, a Sorrento Company, Highlights Safety Data From Phase 1 Trial of SP-104, a Proprietary Low Dose Naltrexone for FibromyalgiaNASDAQ:VCKAVickers Vantage Corporation I
05/05/202219:05GlobeNewswire Inc.Scilex, a Sorrento Company, Announces Pivotal Phase 3 SP-102 (SEMDEXA™) Data Presentation At The American Society Of Interventional Pain (ASIPP) 2022 Annual MeetingNASDAQ:VCKAVickers Vantage Corporation I
 Showing the most relevant articles for your search:NASDAQ:VCKA

Su Consulta Reciente

COIN
ETHUSD
Ethereum
USI
USTECH100
US Tech 100
USOTC
RHHBY
Roche (QX)
NYSE
MRK
Merck
CCOM
SILVER
SILVER
NYSE
CVX
Chevron
NYSE
NKE
Nike
NASDAQ
GOOGL
Alphabet
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NYSE
MCD
McDonalds
AMEX
XLV
Health Care Select Sector
AMEX
XLF
Financial Select Sector
USOTC
ADDYY
Adidas (QX)
USOTC
BNPQY
BNP Paribas (QX)
USOTC
DTEGY
Deutsche Telekom (QX)
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados